Aimmune Therapeutics Stock Price - AIMT

0.03 (0.11%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Aimmune Therapeutics Inc AIMT NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.33 -1.17% 27.97 27.55 28.3883 28.30 28.30 23:59:37
Bid Price Ask Price Spread Spread % News
26.67 30.05 3.38 11.25% 8 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
8,323 1,041,084 $ 28.01 $ 29,155,824 1,893,822 16.95 - 39.71
Last Trade Time Type Quantity Stock Price Currency
19:59:28 2 $ 28.00 USD

Aimmune Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 1.82B 65.04M $ -210.75M -3.67 - 63.96M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Aimmune Therapeutics News

Loading Messages....

Latest AIMT Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AIMT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week29.2929.9327.4728.681,383,949-1.32-4.51%
1 Month36.8039.7127.4731.162,188,878-8.83-23.99%
3 Months26.7439.7126.3531.621,317,8981.234.6%
6 Months21.1139.7118.9428.021,120,2686.8632.5%
1 Year23.7339.7116.9525.76837,8714.2417.87%
3 Years19.0742.0015.9727.17624,1518.9046.67%
5 Years17.5042.009.7725.85488,57710.4759.83%

Aimmune Therapeutics Description

Aimmune Therapeutics Inc is a company operating in the United States biotechnology industry. Its main focus is in the development of product candidates to combat peanut and other food allergies. The company's therapeutic approach, which is referred to as Characterized Oral Desensitization Immunotherapy, is a system designed to desensitize patients to food allergens using characterized biologic products, defined treatment protocols, and support services.

Your Recent History
Aimmune Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.